Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$190.52 - $236.72 $12.6 Million - $15.6 Million
-65,900 Reduced 75.57%
21,300 $4.94 Million
Q1 2024

May 14, 2024

BUY
$212.02 - $267.71 $530,050 - $669,275
2,500 Added 2.95%
87,200 $18.8 Million
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $779,065 - $937,790
3,500 Added 4.31%
84,700 $21.9 Million
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $15 Million - $17 Million
-59,300 Reduced 42.21%
81,200 $20.9 Million
Q2 2023

Aug 11, 2023

SELL
$275.25 - $318.06 $20.9 Million - $24.2 Million
-76,100 Reduced 35.13%
140,500 $40 Million
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $73.7 Million - $83.9 Million
-287,100 Reduced 57.0%
216,600 $60.2 Million
Q4 2022

Feb 10, 2023

BUY
$252.44 - $306.72 $82.5 Million - $100 Million
326,900 Added 184.9%
503,700 $139 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $13.9 Million - $19.2 Million
71,600 Added 68.06%
176,800 $47.2 Million
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $10.7 Million - $12.7 Million
-57,000 Reduced 35.14%
105,200 $21.5 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $19.4 Million - $24.4 Million
-99,900 Reduced 38.12%
162,200 $34.2 Million
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $53.2 Million - $68.4 Million
237,800 Added 978.6%
262,100 $62.9 Million
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $20 Million - $26 Million
-70,500 Reduced 74.37%
24,300 $6.88 Million
Q2 2021

Aug 13, 2021

SELL
$259.0 - $414.71 $41.1 Million - $65.9 Million
-158,800 Reduced 62.62%
94,800 $32.8 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $39.6 Million - $46.5 Million
-163,200 Reduced 39.16%
253,600 $70.9 Million
Q4 2020

Feb 12, 2021

BUY
$236.26 - $355.63 $4.37 Million - $6.58 Million
18,500 Added 4.64%
416,800 $102 Million
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $57.3 Million - $66.1 Million
216,300 Added 118.85%
398,300 $113 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $18.6 Million - $24.7 Million
-72,000 Reduced 28.35%
182,000 $48.7 Million
Q1 2020

May 14, 2020

BUY
$268.85 - $341.04 $19.8 Million - $25.2 Million
73,800 Added 40.95%
254,000 $80.4 Million
Q4 2019

Feb 13, 2020

BUY
$220.06 - $304.07 $23 Million - $31.7 Million
104,300 Added 137.42%
180,200 $53.5 Million
Q3 2019

Nov 08, 2019

BUY
$217.44 - $243.88 $5.63 Million - $6.32 Million
25,900 Added 51.8%
75,900 $17.7 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $6.27 Million - $6.91 Million
28,600 Added 133.64%
50,000 $11.7 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $1.13 Million - $1.76 Million
-5,200 Reduced 19.55%
21,400 $5.06 Million
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $38.4 Million - $48.6 Million
-137,800 Reduced 83.82%
26,600 $8 Million
Q3 2018

Nov 13, 2018

BUY
$293.51 - $383.83 $48.3 Million - $63.1 Million
164,400 New
164,400 $58.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.